跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
艾卡特 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Tirofiban Hydrochloride Concentrated Solution for Injection
Approved
化学药品
Tirofiban Hydrochloride Concentrated Solution for Injection
CORREVIO (AUSTRALIA) PTY LTD
🇨🇳 National Medical Products Administration
Approval Date
Nov 7, 2024
Approval ID
8enLqXpcnC1
Company
CORREVIO (AUSTRALIA) PTY LTD
Type
化学药品
Approval Details
Approval Id
8enLqXpcnC1
Approval Number
国药准字HJ20150589
Generic Name
盐酸替罗非班注射用浓溶液
Generic Name En
Tirofiban Hydrochloride Concentrated Solution for Injection
Trade Name
艾卡特
Drug Type
化学药品
Dosage Form
注射剂
Strength
50ml:12.5mg(以C₂₂H₃₆N₂O₅S计)
Reg Date
2024-11-07
Expired Date
2029-11-06
Company Name
CORREVIO (AUSTRALIA) PTY LTD
Production Company Name
Patheon Manufacturing Services LLC
Company Detail Path
/organization/correvio-australia-pty-ltd
Production Company Detail Path
/organization/patheon-manufacturing-services-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 7, 2024
Approval ID
8enLqXpcnC1
Type
化学药品
Back to NMPA Approvals